MHRA Drug Safety Update - Risperidone and paliperidone: risk of floppy iris syndrome
Central nervous system
The colour classification was determined as part of the collaborative work between LCFT and Medicines Management leads. Local pathways and patient safety were taken into consideration.
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria